Skip to content

Repeated peripheral magnetic stimulation combined with FM® for knee osteoarthritis: a clinical randomized controlled trial

Repeated peripheral magnetic stimulation combined with FM® for knee osteoarthritis: a clinical randomized controlled trial - Repeated randomized controlled clinical trial of peripheral magnetic stimulation combined with FM® for knee osteoarthritis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090897
Enrollment
Unknown
Registered
2024-10-15
Start date
2024-09-10
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

FM group:This group of patients received only FM therapy without rPMS intervention. Cerebral blood oxygen content was measured by fNIRS and surface myoelectric activity was measured by sEMG before and
rPMS group:This group of patients received rPMS only, excluding FM. Cerebral blood oxygen content was measured by fNIRS and surface myoelectric activity was measured by sEMG before and after treatment
Combined treatment group:This group of patients received a combination of rPMS and FM. Cerebral blood oxygen content was measured by fNIRS and surface myoelectric activity was measured by sEMG before

Sponsors

Xingguo Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients with knee osteoarthritis: ? Age 18-80 years old; Unilateral KOA patients diagnosed by imaging or arthroscopy; (3) Kellgren-lawrenceRating Level III (inclusive) or below; (4) Visual analogue scale (VAS) score is greater than 3 points; ? Normal cognitive function, no craniocerebral injury, cerebrovascular disease, epilepsy and other concurrent diseases, no history of craniocerebral surgery; ? No pacemaker or stent implanted in the body; ? Voluntarily accept the treatment program, ? sign the informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: ? Patients with rheumatism or rheumatoid disease, severe osteoporosis; Patients with cognitive impairment, or inability to read, write, or understand text; Pregnant or lactating women; ? Active tumor, active inflammation; (5) Oral analgesia and other drugs; Used hormone therapy; ? Patients with a history of epilepsy and a family history of epilepsy; ? There are metal foreign bodies in the skull, people with cardiac pacemakers, heart stents, people with cochlear implants, and people with increased intracranial pressure.

Design outcomes

Primary

MeasureTime frame
Surface electromyography;

Secondary

MeasureTime frame
Functional near infrared spectroscopy;

Countries

China

Contacts

Public ContactZhang Zhongguo

Xingguo Hospital of Traditional Chinese Medicine

874953314@qq.com+86 152 7971 8924

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026